Northwest Biotherapeutics annual gross margin
2010
2011
2012
2013
Northwest Biotherapeutics Gross Margin Growth & History (NWBO)
Northwest Biotherapeutics's gross margin was 100.00% for fiscal 2013.
View full Northwest Biotherapeutics company overviewNorthwest Biotherapeutics annual gross margin history
| Fiscal year | Period ended | Gross margin | Change (percentage points) |
|---|---|---|---|
| 2013 | 2013-12-31 | 100.00% | 0.00 pp |
| 2012 | 2012-12-31 | 100.00% | 0.00 pp |
| 2011 | 2011-12-31 | 100.00% | 0.00 pp |
| 2010 | 2010-12-31 | 100.00% | — |
Northwest Biotherapeutics quarterly gross margin
Q3.10
Q3.11
Q2.12
Q3.12
Q4.12
Q1.13
Q2.13
Q3.13
| Fiscal quarter | Period ended | Gross margin | Change (percentage points) |
|---|---|---|---|
| Q3 2013 | 2013-09-30 | 100.00% | 0.00 pp |
| Q2 2013 | 2013-06-30 | 100.00% | 0.00 pp |
| Q1 2013 | 2013-03-31 | 100.00% | — |
| Q4 2012 | 2012-12-31 | 100.00% | — |
| Q3 2012 | 2012-09-30 | 100.00% | 0.00 pp |
| Q2 2012 | 2012-06-30 | 100.00% | — |
| Q3 2011 | 2011-09-30 | 100.00% | 0.00 pp |
| Q3 2010 | 2010-09-30 | 100.00% | — |
Northwest Biotherapeutics gross margin trends
Between the periods ended 2010-12-31 and 2013-12-31, Northwest Biotherapeutics's gross margin increased from 100.00% to 100.00%, a change of 0.00 percentage points. The latest reported quarter, Q3 2013, shows 100.00%.
About the metric
What gross margin means
Gross margin measures the percentage of revenue remaining after the direct costs of producing goods or services. It helps show how efficiently a company turns sales into gross profit before operating expenses.
Calculation and source
How gross margin is calculated
TickerStat calculates gross margin as SEC-reported gross profit divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Northwest Biotherapeutics source filings ↗